Rationale for chemotherapy for patients with advanced non-small-cell lung cancer.
Patients with advanced non-small-cell lung cancer (NSCLC) are difficult to treat effectively. There is a strong rationale to continue clinical investigation, since this approach has been useful for other groups of patients with "resistant" tumors. This report reviews the major reasons to consider chemotherapy in these patients, and discusses several other important auxiliary issues.